US2009176260A1PendingUtilityA1
Double-fusion human embryonic stem cells, methods of making double-fusion human embryonic stem cells, triple-fusion human embryonic stem cells, methods of making triple-fusion human embryonic stem cells, and methods of monitoring double-fusion human embryonic stem cells and triple-fusion human embryonic stem cells
Est. expiryDec 4, 2027(~1.4 yrs left)· nominal 20-yr term from priority
C12N 5/0603C12N 5/0657C12N 5/069C12N 5/0606C12N 2506/02A61K 35/12C12N 2510/00
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Embodiments of the present disclosure include double-fusion human embryonic stem cells, methods of imaging double-fusion human embryonic stem cells, double-fusion polynucleotides, double-fusion proteins, triple-fusion human embryonic stem cells, methods of imaging triple-fusion human embryonic stem cells, triple-fusion polynucleotides, triple-fusion proteins, methods of monitoring the progression of human embryonic stem cells, methods of making isolated double-fusion human embryonic stem cells, methods of making isolated triple-fusion human embryonic stem cells, and the like.
Claims
exact text as granted — not AI-modified1 . An isolated double-fusion human embryonic stem cell (hESC) comprising hESC that:
expresses a firefly luciferase reporter gene encoding a firefly luciferase protein; and expresses an enhanced green fluorescent reporter gene encoding an enhanced green fluorescent protein.
2 . The isolated double-fusion human embryonic stem cell of claim 1 , wherein the hESC is an H9 human embryonic stem cell.
3 . The isolated double-fusion human embryonic stem cell of claim 1 , wherein the firefly luciferase reporter gene has a polynucleotide sequence of SEQ ID NO: 1.
4 . The isolated double-fusion human embryonic stem cell of claim 1 , wherein the enhanced green fluorescent reporter gene has a polynucleotide sequence of SEQ ID NO: 2.
5 . The isolated double-fusion human embryonic stem cell of claim 1 , wherein each of the firefly luciferase reporter gene and the enhanced green fluorescent reporter gene are not silenced after 44 passages.
6 . A method of preparing an isolated double-fusion human embryonic stem cell (hESC), comprising:
providing a human embryonic stem cell; transducing the human embryonic stem cell with an expression vector including Fluc and eGFP, Fluc is a firefly luciferase reporter gene and eGFP is enhanced green fluorescent reporter gene.
7 . The method of claim 6 , wherein the expression vector is LV-pUP-Fluc-eGFP, wherein LV is lentivirus, pUP is constituitve human ubiquitin promoter, Fluc is firefly luciferase reporter gene, and eGFP is enhanced green fluorescent reporter gene.
8 . A method of monitoring double-fusion human embryonic stem cell, comprising:
providing an isolated double-fusion human embryonic stem cell (hESC) of claims 1 to 5 ; and detecting fluorescence, bioluminescence, or both fluorescence and bioluminescence emitted from the double-fusion hESC and progeny thereof.
9 . An isolated double-fusion human embryonic stem cell (hESC) comprising an hESC that includes a double-fusion gene that includes a firefly luciferase reporter gene encoding a firefly luciferase protein and an enhanced green fluorescent reporter gene encoding an enhanced green fluorescent protein.
10 . The isolated double-fusion human embryonic stem cell hESC of claim 9 , wherein the double-fusion gene includes a LV-pUP-Fluc-eGFP, wherein LV is lentivirus, pUP is constituitve human ubiquitin promoter, Fluc is firefly luciferase reporter gene, and eGFP is enhanced green fluorescent reporter gene.
11 . The isolated double-fusion human embryonic stem cells hESC of claim 10 , wherein the LV-pUP-Fluc-eGFP has a SEQ ID No; 10.
12 . An isolated triple-fusion human embryonic stem cells (hESC) comprising hESC that:
expresses a firefly luciferase reporter gene encoding a firefly luciferase protein, expresses a red fluorescent reporter gene encoding a red fluorescent protein, and expresses a Herpes Simplex Virus 1 thymidine kinase (HSV1-tk) positron emission tomography (PET) reporter gene encoding an enzyme protein (HSV1-TK).
13 . The isolated triple-fusion human embryonic stem cell (hESC) of claim 12 , wherein the HSV1-tk is a truncated HSV1-tk (HSV1-ttk), and the HSV1-TK is a truncated HSV1-TK (HSV1-tTK).
14 . A method of preparing isolated double-fusion human embryonic stem cells (hESC), comprising:
providing a human embryonic stem cell; transducing the human embryonic stem cell with an expression vector including Fluc, RFP, and tTK, Fluc is a firefly luciferase reporter gene, mRFP is the red fluorescent reporter gene, and tTK is the truncated HSV1-tk PET reporter gene.
15 . The method of claim 14 , wherein the expression vector is LV-pUP-Fluc-RFP-tTK, where LV is lentivirus, pUP is constituitve human ubiquitin promoter, Fluc is firefly luciferase reporter gene, mRFP is the red fluorescent reporter gene, and tTK is the truncated HSV1-tk PET reporter gene.
16 . A method of monitoring triple-fusion human embryonic stem cells, comprising:
providing an isolated triple-fusion human embryonic stem cells (hESC) of claims 12 to 13 ; and detecting fluorescence, bioluminescence, or both fluorescence, and bioluminescence emitted from the triple-fusion hESC and progeny thereof.Join the waitlist — get patent alerts
Track US2009176260A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.